These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36995939)
21. Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen. Wang C; Lai AY; Baiu DC; Smith KA; Odorico JS; Wilson K; Schreiber T; de Silva S; Gumperz JE J Immunol; 2024 Jan; 212(2):284-294. PubMed ID: 37991420 [TBL] [Abstract][Full Text] [Related]
22. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation. Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636 [TBL] [Abstract][Full Text] [Related]
23. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation. Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905 [TBL] [Abstract][Full Text] [Related]
24. Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells. Gu S; Nawrocka W; Adams EJ Front Immunol; 2014; 5():688. PubMed ID: 25657647 [TBL] [Abstract][Full Text] [Related]
26. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More. Herrmann T; Karunakaran MM Front Immunol; 2022; 13():876493. PubMed ID: 35371078 [TBL] [Abstract][Full Text] [Related]
27. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells. Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569 [TBL] [Abstract][Full Text] [Related]
28. Butyrophilin-like 3 Directly Binds a Human Vγ4 Willcox CR; Vantourout P; Salim M; Zlatareva I; Melandri D; Zanardo L; George R; Kjaer S; Jeeves M; Mohammed F; Hayday AC; Willcox BE Immunity; 2019 Nov; 51(5):813-825.e4. PubMed ID: 31628053 [TBL] [Abstract][Full Text] [Related]
29. BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Gay L; Mezouar S; Cano C; Foucher E; Gabriac M; Fullana M; Madakamutil L; Mège JL; Olive D Front Immunol; 2022; 13():915244. PubMed ID: 35833118 [TBL] [Abstract][Full Text] [Related]
30. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production. Alice AF; Kramer G; Bambina S; Bahjat KS; Gough MJ; Crittenden MR Sci Rep; 2021 Aug; 11(1):16347. PubMed ID: 34381163 [TBL] [Abstract][Full Text] [Related]
31. Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones. De Libero G; Lau SY; Mori L Front Immunol; 2014; 5():679. PubMed ID: 25642230 [TBL] [Abstract][Full Text] [Related]
32. The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells. Karunakaran MM; Herrmann T Front Immunol; 2014; 5():648. PubMed ID: 25566259 [TBL] [Abstract][Full Text] [Related]
33. Up-regulation of BTN3A1 on CD14 Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286 [TBL] [Abstract][Full Text] [Related]
34. Vγ9+Vδ2+ T cell control of Listeria monocytogenes growth in infected epithelial cells requires butyrophilin 3A genes. Fischer K; Bradlerova M; Decker T; Supper V Sci Rep; 2023 Oct; 13(1):18651. PubMed ID: 37903831 [TBL] [Abstract][Full Text] [Related]
35. Antigen recognition by human γδ T cells: one step closer to knowing. Eberl M Immunol Cell Biol; 2020 May; 98(5):351-354. PubMed ID: 32329107 [TBL] [Abstract][Full Text] [Related]
36. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells. Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075 [TBL] [Abstract][Full Text] [Related]
37. An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells. Herrmann T; Fichtner AS; Karunakaran MM Cells; 2020 Jun; 9(6):. PubMed ID: 32527033 [TBL] [Abstract][Full Text] [Related]
38. The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. Palakodeti A; Sandstrom A; Sundaresan L; Harly C; Nedellec S; Olive D; Scotet E; Bonneville M; Adams EJ J Biol Chem; 2012 Sep; 287(39):32780-90. PubMed ID: 22846996 [TBL] [Abstract][Full Text] [Related]
39. Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells. Wang H; Morita CT J Immunol; 2015 Nov; 195(10):4583-94. PubMed ID: 26475929 [TBL] [Abstract][Full Text] [Related]
40. EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules. Liu Y; Lui KS; Ye Z; Fung TY; Chen L; Sit PY; Leung CY; Mak NK; Wong KL; Lung HL; Tanaka Y; Cheung AKL Theranostics; 2023; 13(2):458-471. PubMed ID: 36632221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]